BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Discovery

Google DeepMind and Isomorphic Labs Launch AI Model Transforming Drug Discovery and Biological Understanding

DeepMind has unveiled AlphaFold 3, a cutting-edge AI model that significantly enhances our understanding of molecular structures and interactions, crucial ...

May 10, 2024 | News

DevPro Biopharma and Bespak Complete Early Feasibility Studies for New Groundbreaking Albuterol Inhaler

DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered do...

May 08, 2024 | News

Everest Medicines Secures NDA Approval for Nefecon® in Hong Kong, Expanding Treatment Reach in Asia

Everest Medicines announced that the Hong Kong Department of Health had approved Nefecon® for the treatment of primary immunoglobulin A nephropath...

May 02, 2024 | News

Chipscreen's Chidamide Receives NMPA Approval for First-Line Treatment of DLBCL with MYC/BCL2 Expression

Shenzhen Chipscreen Biosciences announced that the company's lead innovative product Chidamide (Epidaza®) , an oral subtype-selective histone deacetyla...

May 01, 2024 | News

Pfizer and Genmab's TIVDAK Wins FDA Full Approval for Cervical Cancer After Outperforming Chemotherapy in Key Trial

TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastat...

April 30, 2024 | News

EMA's CHMP Recommends Approval of Pierre Fabre's OBGEMSA™ for Overactive Bladder

Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted ...

April 29, 2024 | News

Fosun Pharma's Artemisinin Medicines Boost Malaria Fight in Africa

Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly endanger health and cost lives, b...

April 29, 2024 | News

Hyundai Bioscience Targets p53 Gene Mutations with Novel Niclosamide-Based Cancer Therapy

The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatm...

April 26, 2024 | News

PRISM BioLab and ONO Pharmaceutical Forge Strategic Collaboration to Advance Oncology Drug Development

PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein int...

April 26, 2024 | News

OSR Holdings and SillaJen Forge Strategic Partnership to Enhance Immuno-Oncology Drug Development

OSR Holdings, a global healthcare holding company, announced that it has signed a memorandum of understanding (MOU) with SillaJen, a Kosdaq-listed biotech ...

April 23, 2024 | News

Hyundai Bioscience Launches Clinical Trials for Innovative Niclosamide-Based Cancer Drug

Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative...

April 23, 2024 | News

Hyundai Bioscience to Conduct Global Clinical Trials for Groundbreaking Dengue Treatment

Hyundai Bioscience CEO Oh Sang-gi, announced its plan to launch global clinical trials for a revolutionary treatment targeting all four serotypes of ...

April 22, 2024 | News

X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

"This submission was the culmination of several years of development activities and the establishment of a Good Manufacturing Practices (GMP) manufacturing...

April 19, 2024 | News

Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery

Solutions address shift from animal-based to more human-relevant organoid models, resulting in more accurate predictions in drug discovery Synergies wit...

April 10, 2024 | News

Stay Connected